Carbapenem-resistant Enterobacteriaceae Testing Market, Global Outlook and Forecast 2022-2028

July 2024 | 60 pages | ID: C2CC03235234EN
Market Monitor Global

Abstracts

Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.

This report contains market size and forecasts of Carbapenem-resistant Enterobacteriaceae Testing in Global, including the following market information:

Global Carbapenem-resistant Enterobacteriaceae Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Carbapenem-resistant Enterobacteriaceae Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Carbapenem-resistant Enterobacteriaceae Testing include TBA, SolGent, ELITechGroup, ALIFAX and BioM?rieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Carbapenem-resistant Enterobacteriaceae Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Carbapenem-resistant Enterobacteriaceae Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Carbapenem-resistant Enterobacteriaceae Testing Market Segment Percentages, by Type, 2021 (%)

• Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
• Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
• Other Types

Global Carbapenem-resistant Enterobacteriaceae Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Carbapenem-resistant Enterobacteriaceae Testing Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Carbapenem-resistant Enterobacteriaceae Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Carbapenem-resistant Enterobacteriaceae Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Carbapenem-resistant Enterobacteriaceae Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Carbapenem-resistant Enterobacteriaceae Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• TBA
• SolGent
• ELITechGroup
• ALIFAX
• BioM?rieux

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Carbapenem-resistant Enterobacteriaceae Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Carbapenem-resistant Enterobacteriaceae Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CARBAPENEM-RESISTANT ENTEROBACTERIACEAE TESTING OVERALL MARKET SIZE

2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Size: 2021 VS 2028
2.2 Global Carbapenem-resistant Enterobacteriaceae Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Carbapenem-resistant Enterobacteriaceae Testing Players in Global Market
3.2 Top Global Carbapenem-resistant Enterobacteriaceae Testing Companies Ranked by Revenue
3.3 Global Carbapenem-resistant Enterobacteriaceae Testing Revenue by Companies
3.4 Top 3 and Top 5 Carbapenem-resistant Enterobacteriaceae Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Carbapenem-resistant Enterobacteriaceae Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Carbapenem-resistant Enterobacteriaceae Testing Players in Global Market
  3.6.1 List of Global Tier 1 Carbapenem-resistant Enterobacteriaceae Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Carbapenem-resistant Enterobacteriaceae Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Markets, 2021 & 2028
  4.1.2 Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
  4.1.3 Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
  4.1.4 Other Types
4.2 By Type - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue & Forecasts
  4.2.1 By Type - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2022
  4.2.2 By Type - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2023-2028
  4.2.3 By Type - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue & Forecasts
  5.2.1 By Application - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2022
  5.2.2 By Application - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2023-2028
  5.2.3 By Application - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2021 & 2028
6.2 By Region - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue & Forecasts
  6.2.1 By Region - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2022
  6.2.2 By Region - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2023-2028
  6.2.3 By Region - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2028
  6.3.2 US Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.3.3 Canada Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.3.4 Mexico Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2028
  6.4.2 Germany Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.4.3 France Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.4.4 U.K. Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.4.5 Italy Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.4.6 Russia Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.4.8 Benelux Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2028
  6.5.2 China Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.5.3 Japan Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.5.4 South Korea Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.5.6 India Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2028
  6.6.2 Brazil Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.6.3 Argentina Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2028
  6.7.2 Turkey Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.7.3 Israel Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028
  6.7.5 UAE Carbapenem-resistant Enterobacteriaceae Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 TBA
  7.1.1 TBA Corporate Summary
  7.1.2 TBA Business Overview
  7.1.3 TBA Carbapenem-resistant Enterobacteriaceae Testing Major Product Offerings
  7.1.4 TBA Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global Market (2017-2022)
  7.1.5 TBA Key News
7.2 SolGent
  7.2.1 SolGent Corporate Summary
  7.2.2 SolGent Business Overview
  7.2.3 SolGent Carbapenem-resistant Enterobacteriaceae Testing Major Product Offerings
  7.2.4 SolGent Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global Market (2017-2022)
  7.2.5 SolGent Key News
7.3 ELITechGroup
  7.3.1 ELITechGroup Corporate Summary
  7.3.2 ELITechGroup Business Overview
  7.3.3 ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Major Product Offerings
  7.3.4 ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global Market (2017-2022)
  7.3.5 ELITechGroup Key News
7.4 ALIFAX
  7.4.1 ALIFAX Corporate Summary
  7.4.2 ALIFAX Business Overview
  7.4.3 ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Major Product Offerings
  7.4.4 ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global Market (2017-2022)
  7.4.5 ALIFAX Key News
7.5 BioM?rieux
  7.5.1 BioM?rieux Corporate Summary
  7.5.2 BioM?rieux Business Overview
  7.5.3 BioM?rieux Carbapenem-resistant Enterobacteriaceae Testing Major Product Offerings
  7.5.4 BioM?rieux Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global Market (2017-2022)
  7.5.5 BioM?rieux Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Carbapenem-resistant Enterobacteriaceae Testing Market Opportunities & Trends in Global Market
Table 2. Carbapenem-resistant Enterobacteriaceae Testing Market Drivers in Global Market
Table 3. Carbapenem-resistant Enterobacteriaceae Testing Market Restraints in Global Market
Table 4. Key Players of Carbapenem-resistant Enterobacteriaceae Testing in Global Market
Table 5. Top Carbapenem-resistant Enterobacteriaceae Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Carbapenem-resistant Enterobacteriaceae Testing Product Type
Table 9. List of Global Tier 1 Carbapenem-resistant Enterobacteriaceae Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Carbapenem-resistant Enterobacteriaceae Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Carbapenem-resistant Enterobacteriaceae Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2023-2028
Table 30. TBA Corporate Summary
Table 31. TBA Carbapenem-resistant Enterobacteriaceae Testing Product Offerings
Table 32. TBA Carbapenem-resistant Enterobacteriaceae Testing Revenue (US$, Mn), (2017-2022)
Table 33. SolGent Corporate Summary
Table 34. SolGent Carbapenem-resistant Enterobacteriaceae Testing Product Offerings
Table 35. SolGent Carbapenem-resistant Enterobacteriaceae Testing Revenue (US$, Mn), (2017-2022)
Table 36. ELITechGroup Corporate Summary
Table 37. ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Product Offerings
Table 38. ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Revenue (US$, Mn), (2017-2022)
Table 39. ALIFAX Corporate Summary
Table 40. ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Product Offerings
Table 41. ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Revenue (US$, Mn), (2017-2022)
Table 42. BioM?rieux Corporate Summary
Table 43. BioM?rieux Carbapenem-resistant Enterobacteriaceae Testing Product Offerings
Table 44. BioM?rieux Carbapenem-resistant Enterobacteriaceae Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Carbapenem-resistant Enterobacteriaceae Testing Segment by Type in 2021
Figure 2. Carbapenem-resistant Enterobacteriaceae Testing Segment by Application in 2021
Figure 3. Global Carbapenem-resistant Enterobacteriaceae Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Carbapenem-resistant Enterobacteriaceae Testing Revenue in 2021
Figure 8. By Type - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
Figure 12. US Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
Figure 16. Germany Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
Figure 24. China Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Carbapenem-resistant Enterobacteriaceae Testing Revenue, (US$, Mn), 2017-2028
Figure 37. TBA Carbapenem-resistant Enterobacteriaceae Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. SolGent Carbapenem-resistant Enterobacteriaceae Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BioM?rieux Carbapenem-resistant Enterobacteriaceae Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)